サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1482417

単一細胞分析市場：製品タイプ別、エンドユーザー別、地域別 - 世界の産業分析、規模、シェア、成長、動向、予測、2024～2032年

Single-Cell Analysis Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日
ページ情報
英文 301 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
単一細胞分析市場：製品タイプ別、エンドユーザー別、地域別 - 世界の産業分析、規模、シェア、成長、動向、予測、2024～2032年
出版日: 2024年05月14日
発行: Persistence Market Research
ページ情報: 英文 301 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchは、単一細胞分析市場を詳細に分析し、その多面的なダイナミクスと予測される将来動向に関する詳細な洞察を提供しています。この包括的なレポートは、市場開拓、促進力、障害、新興パターンを網羅し、2024年から2032年までの重要な統計と予測を提供します。

主要な洞察

  • 単一細胞分析市場規模（2024年）：57億米ドル
  • 予測市場金額（2032年）：245億2,000万米ドル
  • 世界市場成長率（CAGR、2024～2032年）：23.17%

単一細胞分析市場 - 調査範囲：

同市場は、細胞の不均一性と疾患メカニズムの理解を深めるために不可欠な様々なアプリケーションで構成されています。単一細胞分析技術は、研究者が複雑な生物学的システムを細胞レベルで解剖することを可能にし、細胞の多様性、遺伝子発現プロファイル、バイオマーカー同定に関する洞察を提供します。この市場は、がん研究、免疫学、神経科学、幹細胞生物学など様々な分野での単一細胞分析の応用拡大により、大きく成長しています。さらに、単一細胞分析プラットフォームの技術的進歩とライフサイエンス研究への投資の増加が市場拡大を後押ししています。

市場成長の促進要因：

単一細胞分析市場の成長を後押しする要因は数多くあります。がんや神経変性疾患のような疾患における細胞の不均一性を解読するための高解像度細胞分析ツールに対する需要の高まりは、重要な促進要因です。さらに、液滴ベース法や空間トランスクリプトミクスなどの単一細胞シーケンス技術の進歩が、単一細胞分析アプリケーションの範囲を拡大しています。さらに、学術研究機関、製薬会社、技術プロバイダー間の協力が、単一細胞分析プラットフォームの技術革新を促進し、市場成長を促進しています。

市場抑制要因：

有望な市場であるにもかかわらず、単一細胞分析市場はいくつかの課題に直面しています。装置コストの高さとデータ解析の複雑さが、特にリソースに制約のある環境において、単一細胞分析技術の普及に大きな障壁となっています。さらに、単一細胞データの解釈と実験プロトコルの標準化は、研究者にとって依然として重要な課題です。さらに、データの再現性に関する懸念や、強固な品質管理対策の必要性も、市場の成長をある程度妨げています。

市場機会：

単一細胞分析市場には、技術革新と成長の機会が豊富にあります。単一細胞分離技術の進歩は、マルチオミクスアプローチの統合と相まって、個別化医療や創薬における単一細胞分析の応用領域を拡大する可能性を秘めています。さらに、単一細胞空間プロファイリング技術の出現は、様々な病態における組織微小環境や細胞間相互作用の研究に新たな道を提供します。さらに、新規の単一細胞分析アッセイやバイオマーカー探索プラットフォームを開発するための技術開発者と製薬企業との戦略的提携は、市場拡大に拍車をかける可能性が高いです。

本レポートで扱う主要な質問

  • 単一細胞分析市場の世界の成長を促進する主要な要因は何か？
  • 技術の進歩は単一細胞分析技術の開発と採用にどのような影響を与えているか？
  • 市場参入企業にとっての主要な課題と機会は何か？
  • 最も高い成長が期待できる研究分野と治療用途は？
  • 市場ポジションを強化し、研究者や臨床医の進化するニーズに対応するために、主要企業はどのような戦略を採用しているのか？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限

第3章 市場背景

  • 市場力学
  • シナリオ予測
  • 機会マップ分析
  • 投資実現可能性マトリックス
  • PESTLEとポーター分析
  • 規制状況
  • 地域別の親市場展望

第4章 世界の単一細胞分析市場分析

  • 過去の市場規模金額分析、2019～2023年
  • 現在および将来の市場規模金額予測：2024～2032年
    • 前年比成長動向分析
    • 絶対額の機会分析

第5章 世界の単一細胞分析市場分析：製品別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模金額分析：製品別、2019～2023年
  • 現在および将来の市場規模金額分析と予測：製品別、2024～2032年
    • 消耗品
    • 機器
  • 前年比成長動向分析：製品別、2019～2023年
  • 絶対額の機会分析：製品別、2024～2032年

第6章 世界の単一細胞分析市場分析：用途別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模金額分析：用途別、2019～2023年
  • 現在および将来の市場規模金額分析と予測：用途別、2024～2032年
    • がん
    • 免疫学
    • 神経学
    • 幹細胞
    • 非侵襲的出生前診断
    • 体外受精
    • その他
  • 前年比成長動向分析：用途別、2019～2023年
  • 絶対額の機会分析：用途別、2024～2032年

第7章 世界の単一細胞分析市場分析：ワークフロー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模金額分析：ワークフロー別、2019～2023年
  • 現在および将来の市場規模金額分析と予測：ワークフロー別、2024～2032年
    • 単一細胞分離・ライブラリー調製
    • 下流分析
    • データ分析
  • 前年比成長動向分析：ワークフロー別、2019～2023年
  • 絶対額の機会分析：ワークフロー別、2024～2032年

第8章 世界の単一細胞分析市場分析：エンドユーザー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模金額分析：エンドユーザー別、2019～2023年
  • 現在および将来の市場規模金額分析と予測：エンドユーザー別、2024～2032年
    • 学術・研究機関
    • バイオテクノロジー・製薬会社
    • 病院・診断研究所
    • その他
  • 前年比成長動向分析：エンドユーザー別、2019～2023年
  • 絶対額の機会分析：エンドユーザー別、2024～2032年

第9章 世界の単一細胞分析市場分析：地域別

  • イントロダクション
  • 過去の市場規模金額分析：地域別、2019～2023年
  • 現在の市場規模金額分析と予測：地域別、2024～2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第10章 北米の単一細胞分析市場分析：国別

第11章 ラテンアメリカの単一細胞分析市場分析：国別

第12章 欧州の単一細胞分析市場分析：国別

第13章 アジア太平洋の単一細胞分析市場分析：国別

第14章 中東・アフリカの単一細胞分析市場分析：国別

第15章 主要国の単一細胞分析市場分析

  • 米国
  • カナダ
  • ブラジル
  • メキシコ
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • 中国
  • 日本
  • 韓国
  • シンガポール
  • タイ
  • インドネシア
  • オーストラリア
  • ニュージーランド
  • GCC諸国
  • 南アフリカ
  • イスラエル

第16章 市場構造分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 主要企業の市場シェア分析

第17章 競合分析

  • 競合の詳細情報
    • Thermo Fisher Scientific, Inc.
    • QIAGEN NV
    • Bio-Rad Laboratories Inc.
    • Illumina Inc.
    • Merck KGaA
    • Becton, Dickinson &Company
    • Fluidigm Corporation
    • 10x Genomics, Inc.
    • BGI
    • Novogene Corporation

第18章 前提条件と使用される頭字語

第19章 調査手法

目次
Product Code: PMRREP33180

Persistence Market Research provides an in-depth analysis of the Single-Cell Analysis Market, offering detailed insights into its multifaceted dynamics and projected future trends. This comprehensive report encompasses market developments, driving forces, hurdles, and emerging patterns, furnishing crucial statistics and forecasts from 2024 to 2032.

Key Insights:

  • Single-Cell Analysis Market Size (2024): USD 5.70 Billion
  • Projected Market Value (2032): USD 24.52 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 23.17%

Single-Cell Analysis Market - Report Scope:

The market comprises various applications crucial for advancing our understanding of cellular heterogeneity and disease mechanisms. Single-cell analysis technologies enable researchers to dissect complex biological systems at the cellular level, offering insights into cellular diversity, gene expression profiles, and biomarker identification. The market is witnessing substantial growth driven by the expanding applications of single-cell analysis in various fields such as cancer research, immunology, neuroscience, and stem cell biology. Additionally, technological advancements in single-cell analysis platforms, coupled with increasing investments in life sciences research, are propelling market expansion.

Market Growth Drivers:

A multitude of factors propel the growth of the Single-Cell Analysis Market. The rising demand for high-resolution cellular analysis tools to decipher cellular heterogeneity in diseases like cancer and neurodegenerative disorders is a significant driver. Moreover, advancements in single-cell sequencing technologies, such as droplet-based methods and spatial transcriptomics, are expanding the scope of single-cell analysis applications. Furthermore, collaborations between academic research institutions, pharmaceutical companies, and technology providers are fostering innovation in single-cell analysis platforms, thereby driving market growth.

Market Restraints:

Despite its promising prospects, the Single-Cell Analysis Market faces certain challenges. High instrument costs and complexity in data analysis pose significant barriers to the widespread adoption of single-cell analysis technologies, particularly in resource-constrained settings. Moreover, the interpretation of single-cell data and standardization of experimental protocols remain key challenges for researchers. Additionally, concerns regarding data reproducibility and the need for robust quality control measures hinder market growth to some extent.

Market Opportunities:

The Single-Cell Analysis Market presents ample opportunities for innovation and growth. Advancements in single-cell isolation techniques, coupled with the integration of multi-omics approaches, hold promise for expanding the application spectrum of single-cell analysis in personalized medicine and drug discovery. Furthermore, the emergence of single-cell spatial profiling technologies offers new avenues for studying tissue microenvironments and cell-cell interactions in various pathological conditions. Moreover, strategic collaborations between technology developers and pharmaceutical companies to develop novel single-cell analysis assays and biomarker discovery platforms are likely to fuel market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Single-Cell Analysis Market globally?
  • How are technological advancements influencing the development and adoption of single-cell analysis technologies?
  • What are the major challenges and opportunities for market participants?
  • Which research areas and therapeutic applications offer the highest growth potential?
  • What strategies are leading companies employing to strengthen their market position and address the evolving needs of researchers and clinicians?

Competitive Intelligence and Business Strategy:

Key players in the global Single-Cell Analysis Market, including biotechnology companies, instrument manufacturers, and academic research institutions, focus on innovation, product differentiation, and strategic collaborations to maintain their competitive edge. Companies invest in developing cutting-edge single-cell analysis platforms that offer high sensitivity, throughput, and multiplexing capabilities. Additionally, emphasis on user-friendly software solutions for data analysis and visualization enhances the usability of single-cell analysis platforms, driving their adoption among researchers. Strategic partnerships with academic research centers and pharmaceutical companies facilitate technology validation and accelerate the translation of single-cell analysis findings into clinical applications.

Key Companies Profiled:

  • Thermo Fisher Scientific Inc.
  • Qiagen N.V
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • Becton, Dickinson & Company
  • Fluidigm Corporation
  • 10x Genomics Inc.
  • BGI
  • Novogene Corporation

Single-Cell Analysis Market Research Segmentation:

By Consumables

  • Consumables

Reagents

Assay Kits

  • Instruments
  • Manual Instruments

Microscopes

Hemocytometers

Automated Instruments

Flow Cytometers

Next Generation Sequencing

PCR Systems

High-content Screening System

Cell Microarrays

Automated Cell Counters

By Application Type

  • Cancer
  • Immunology
  • Neurology
  • Stem Cell
  • Non-invasive Prenatal Diagnosis
  • In-vitro Fertilization
  • Others

By Workflow

  • Single Cell Isolation & Library Preparation
  • Downstream Analysis
  • Data Analysis

By End User

  • Academic & Research Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostic Laboratories
  • Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 5.3.1. Consumables
      • 5.3.1.1. Reagents
      • 5.3.1.2. Assay Kits
    • 5.3.2. Instruments
      • 5.3.2.1. Manual Instruments
      • 5.3.2.2. Microscopes
      • 5.3.2.3. Hemocytometers
      • 5.3.2.4. Automated Instruments
      • 5.3.2.5. Flow Cytometers
      • 5.3.2.6. Next Generation Sequencing
      • 5.3.2.7. PCR Systems
      • 5.3.2.8. High-content Screening System
      • 5.3.2.9. Cell Microarrays
      • 5.3.2.10. Automated Cell Counters
  • 5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2024-2032
    • 6.3.1. Cancer
    • 6.3.2. Immunology
    • 6.3.3. Neurology
    • 6.3.4. Stem Cell
    • 6.3.5. Non-invasive Prenatal Diagnosis
    • 6.3.6. In-vitro Fertilization
    • 6.3.7. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Application, 2024-2032

7. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Workflow

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Workflow , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Workflow , 2024-2032
    • 7.3.1. Single Cell Isolation & Library Preparation
    • 7.3.2. Downstream Analysis
    • 7.3.3. Data Analysis
  • 7.4. Y-o-Y Growth Trend Analysis By Workflow , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Workflow , 2024-2032

8. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By End-user

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By End-user, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user, 2024-2032
    • 8.3.1. Academic & Research Laboratories
    • 8.3.2. Biotechnology & Pharmaceutical Companies
    • 8.3.3. Hospitals & Diagnostic Laboratories
    • 8.3.4. Others
  • 8.4. Y-o-Y Growth Trend Analysis By End-user, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By End-user, 2024-2032

9. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Workflow
    • 10.2.5. By End-user
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Application
    • 10.3.4. By Workflow
    • 10.3.5. By End-user
  • 10.4. Key Takeaways

11. Latin America Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By Workflow
    • 11.2.5. By End-user
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Application
    • 11.3.4. By Workflow
    • 11.3.5. By End-user
  • 11.4. Key Takeaways

12. Europe Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By Workflow
    • 12.2.5. By End-user
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By Workflow
    • 12.3.5. By End-user
  • 12.4. Key Takeaways

13. Asia Pacific Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. China
      • 13.2.1.2. Japan
      • 13.2.1.3. South Korea
      • 13.2.1.4. Singapore
      • 13.2.1.5. Thailand
      • 13.2.1.6. Indonesia
      • 13.2.1.7. Australia
      • 13.2.1.8. New Zealand
      • 13.2.1.9. Rest of Asia Pacific
    • 13.2.2. By Product
    • 13.2.3. By Application
    • 13.2.4. By Workflow
    • 13.2.5. By End-user
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By Workflow
    • 13.3.5. By End-user
  • 13.4. Key Takeaways

14. MEA Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. GCC Countries
      • 14.2.1.2. South Africa
      • 14.2.1.3. Israel
      • 14.2.1.4. Rest of MEA
    • 14.2.2. By Product
    • 14.2.3. By Application
    • 14.2.4. By Workflow
    • 14.2.5. By End-user
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By Workflow
    • 14.3.5. By End-user
  • 14.4. Key Takeaways

15. Key Countries Single-Cell Analysis Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2024
      • 15.1.2.1. By Product
      • 15.1.2.2. By Application
      • 15.1.2.3. By Workflow
      • 15.1.2.4. By End-user
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2024
      • 15.2.2.1. By Product
      • 15.2.2.2. By Application
      • 15.2.2.3. By Workflow
      • 15.2.2.4. By End-user
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2024
      • 15.3.2.1. By Product
      • 15.3.2.2. By Application
      • 15.3.2.3. By Workflow
      • 15.3.2.4. By End-user
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2024
      • 15.4.2.1. By Product
      • 15.4.2.2. By Application
      • 15.4.2.3. By Workflow
      • 15.4.2.4. By End-user
  • 15.5. Germany
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2024
      • 15.5.2.1. By Product
      • 15.5.2.2. By Application
      • 15.5.2.3. By Workflow
      • 15.5.2.4. By End-user
  • 15.6. U.K.
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2024
      • 15.6.2.1. By Product
      • 15.6.2.2. By Application
      • 15.6.2.3. By Workflow
      • 15.6.2.4. By End-user
  • 15.7. France
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2024
      • 15.7.2.1. By Product
      • 15.7.2.2. By Application
      • 15.7.2.3. By Workflow
      • 15.7.2.4. By End-user
  • 15.8. Spain
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2024
      • 15.8.2.1. By Product
      • 15.8.2.2. By Application
      • 15.8.2.3. By Workflow
      • 15.8.2.4. By End-user
  • 15.9. Italy
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2024
      • 15.9.2.1. By Product
      • 15.9.2.2. By Application
      • 15.9.2.3. By Workflow
      • 15.9.2.4. By End-user
  • 15.10. China
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2024
      • 15.10.2.1. By Product
      • 15.10.2.2. By Application
      • 15.10.2.3. By Workflow
      • 15.10.2.4. By End-user
  • 15.11. Japan
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2024
      • 15.11.2.1. By Product
      • 15.11.2.2. By Application
      • 15.11.2.3. By Workflow
      • 15.11.2.4. By End-user
  • 15.12. South Korea
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2024
      • 15.12.2.1. By Product
      • 15.12.2.2. By Application
      • 15.12.2.3. By Workflow
      • 15.12.2.4. By End-user
  • 15.13. Singapore
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2024
      • 15.13.2.1. By Product
      • 15.13.2.2. By Application
      • 15.13.2.3. By Workflow
      • 15.13.2.4. By End-user
  • 15.14. Thailand
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2024
      • 15.14.2.1. By Product
      • 15.14.2.2. By Application
      • 15.14.2.3. By Workflow
      • 15.14.2.4. By End-user
  • 15.15. Indonesia
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2024
      • 15.15.2.1. By Product
      • 15.15.2.2. By Application
      • 15.15.2.3. By Workflow
      • 15.15.2.4. By End-user
  • 15.16. Australia
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2024
      • 15.16.2.1. By Product
      • 15.16.2.2. By Application
      • 15.16.2.3. By Workflow
      • 15.16.2.4. By End-user
  • 15.17. New Zealand
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2024
      • 15.17.2.1. By Product
      • 15.17.2.2. By Application
      • 15.17.2.3. By Workflow
      • 15.17.2.4. By End-user
  • 15.18. GCC Countries
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2024
      • 15.18.2.1. By Product
      • 15.18.2.2. By Application
      • 15.18.2.3. By Workflow
      • 15.18.2.4. By End-user
  • 15.19. South Africa
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2024
      • 15.19.2.1. By Product
      • 15.19.2.2. By Application
      • 15.19.2.3. By Workflow
      • 15.19.2.4. By End-user
  • 15.20. Israel
    • 15.20.1. Pricing Analysis
    • 15.20.2. Market Share Analysis, 2024
      • 15.20.2.1. By Product
      • 15.20.2.2. By Application
      • 15.20.2.3. By Workflow
      • 15.20.2.4. By End-user

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By Workflow
    • 16.3.5. By End-user

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. Thermo Fisher Scientific, Inc.
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
    • 17.1.2. QIAGEN NV
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
    • 17.1.3. Bio-Rad Laboratories Inc.
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
    • 17.1.4. Illumina Inc.
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
    • 17.1.5. Merck KGaA
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
    • 17.1.6. Becton, Dickinson & Company
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
    • 17.1.7. Fluidigm Corporation
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
    • 17.1.8. 10x Genomics, Inc.
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
    • 17.1.9. BGI
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
    • 17.1.10. Novogene Corporation
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology